DiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Significant Decline in Short Interest

DiaSorin S.p.A. (OTCMKTS:DSRLF) was the recipient of a large decrease in short interest during the month of July. As of July 15th, there was short interest totalling 312,900 shares, a decrease of 35.7% from the June 30th total of 486,900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Analysts Set New Price Targets

Separately, Barclays began coverage on DiaSorin in a research report on Thursday, May 9th. They issued an “equal weight” rating for the company.

DiaSorin Price Performance

Shares of DSRLF remained flat at $99.86 during midday trading on Monday. The stock’s fifty day simple moving average is $105.16 and its 200-day simple moving average is $99.17. DiaSorin has a 12-month low of $86.00 and a 12-month high of $109.00.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.